Results 171 to 180 of about 123,607 (301)

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

open access: yesJournal of Cutaneous Pathology, Volume 53, Issue 5, Page 422-426, May 2026.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina   +5 more
wiley   +1 more source

Global consensus on the management of melanin hyperpigmentation disorders

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 760-772, May 2026.
A global Delphi consensus of 10 dermatology experts established evidence‐based recommendations for melanin hyperpigmentation disorders, providing unified classification, photoprotection guidance and treatment algorithms. This framework harmonizes terminology and supports individualized management across diverse skin types and health systems.
Thierry Passeron   +9 more
wiley   +1 more source

Cutaneous and mucosal manifestations associated with celiac disease [PDF]

open access: yes, 2018
Beteta Gorriti, Valia Patricia   +6 more
core   +2 more sources

Zosteriform Lichen Planus. [PDF]

open access: yesClin Case Rep
Jaiswal S   +4 more
europepmc   +1 more source

Nail lichen planus [PDF]

open access: yesJournal of the American Academy of Dermatology, 2019
Christos, Tziotzios   +2 more
openaire   +2 more sources

Cutaneous and erosive oral lichen planus treated with upadacitinib. [PDF]

open access: yesJAAD Case Rep
Nwogu O   +4 more
europepmc   +1 more source

Disrupted Salivary Fungal Community in Patients With Oral Lichen Planus. [PDF]

open access: yesInt Dent J
Zhang M   +6 more
europepmc   +1 more source

Acute Lichen Planus [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1929
openaire   +3 more sources

Home - About - Disclaimer - Privacy